Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator

Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator

Background and purpose: Recently, intermediate and high-risk prostate cancer patients have been treated in a multicenter phase II trial with extremely hypofractionated prostate radiotherapy (hypo-FLAME trial). The purpose of the current study was to investigate whether a 1.5 T magnetic resonance ima...

Full description

Bibliographic Details
Main Authors: Mariska D. den Hartogh, Hans C.J. de Boer, Eline N. de Groot-van Breugel, Jochem R.N. van der Voort van Zyp, Jochem Hes, Uulke A. van der Heide, Floris Pos, Karin Haustermans, Tom Depuydt, Robert Jan Smeenk, Martina Kunze-Busch, Bas W. Raaymakers, Linda G.W. Kerkmeijer
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Physics and Imaging in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631619300302

Internet

http://www.sciencedirect.com/science/article/pii/S2405631619300302

Similar Items